Covered recipient · General Payments record
RORY HAWKER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$364.42
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $180.84 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $68.01 | 4 |
| Acerta Pharma LLC | $31.96 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.35 | 2 |
| Lilly USA, LLC | $19.43 | 1 |
| Exeltis, USA Inc. | $16.22 | 1 |
| ABBVIE INC. | $15.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.87 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103893549 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.08 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104432879 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.88 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104593114 | CMS |
| Exeltis, USA Inc. | $16.22 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149995038 | CMS |
| Lilly USA, LLC | $19.43 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135339411 | CMS |
| Novartis Pharmaceuticals Corporation | $13.36 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086949677 | CMS |
| Novartis Pharmaceuticals Corporation | $15.99 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086949697 | CMS |
| Novo Nordisk Inc | $13.38 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097534914 | CMS |
| Novo Nordisk Inc | $18.37 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096927906 | CMS |
| Novo Nordisk Inc | $18.73 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097724051 | CMS |
| Novo Nordisk Inc | $17.53 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097309027 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.